Article Details

Biopharma Expects Data Readouts in Psoriasis, NASH in H2/19

Retrieved on: 2019-04-02 23:56:15

Tags for this article:

Click the tags to see associated articles and topics

Biopharma Expects Data Readouts in Psoriasis, NASH in H2/19. View article details on hiswai:

Excerpt

<div>She or members of her household own securities of the following ... 1% or more of any class of common <b>equity securities</b> of DURECT Corporation.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo